Authors


Katherine Hasal

Latest:

Improved Outcomes in Patients with Chronic Hepatitis C Treated with Sofosbuvir Velpatasvir

Treatment with fixed-dos combination sofosbuvir/velpatasvir yielded significant improvements in patient-reported outcomes.


Katherine Hasal, MS

Latest:

CMSC 2012: Oral Teriflunomide Not Superior to Interferon in Risk of Treatment Failure

The oral disease-modifying drug under development for the treatment of relapsing-remitting multiple sclerosis, teriflunomide, was not superior to interferon beta-1a in risk of treatment failure.

© 2024 MJH Life Sciences

All rights reserved.